Ali Behbahani
Chair of the BoardatNkarta· In proxies 2023–2025
Ali Behbahani sits on 13 public boards.
Boards1
- CRISPR Therapeutics AGDirector · 8 yr on the boardIndependentDirectors and Executive, Nominating and Corporate Governance—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- NkartaPublic company · 1 yr
- Chair of the Board2025 – Present · 1 yrStock in role -27%
- CRISPR Therapeutics AGPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Monte Rosa TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Korro Bio, Inc.Public company · 7 yr
- Director2019 – Present · 7 yrNo stock prices for these years
- SpyGlass Pharma, Inc.Public company · 7 yr
- Director2019 – Present · 7 yrNo stock prices for these years
- Black Diamond Therapeutics, Inc.Public company · 8 yr
- Director2018 – Present · 8 yrNo stock prices for these years
- Arcellx, Inc.Public company · 11 yr
- Director2015 – Present · 11 yrNo stock prices for these years
- Nkarta, Inc.Public company · 11 yr
- Director2015 – Present · 11 yrNo stock prices for these years
- Adaptimmune TherapeuticsPublic company · 11 yr
- Director2014 – 2025 · 11 yrNo stock prices for these years
- CVRx, Inc.Public company · 11 yr
- Director2013 – 2024 · 11 yrNo stock prices for these years
- Minerva Surgical Inc.Public company · 13 yr
- Director2011 – 2024 · 13 yrNo stock prices for these years
- Oyster Point Pharma, Inc.Public company · 6 yr
- Director2017 – 2023 · 6 yrNo stock prices for these years
- Genocea Biosciences, Inc.Public company · 4 yr
- Director2018 – 2022 · 4 yrNo stock prices for these years
- Nevro Corp.Public company · 5 yr
- Director2014 – 2019 · 5 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?